Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sergey Berezin Medical Institute (MIBS) is a leading private healthcare provider in Russia, specializing in high-tech diagnostic imaging and oncology treatment. Founded in 2003, the institute operates an extensive network of over 90 MRI and CT centers across Russia and neighboring countries. MIBS is notably recognized for its advanced radiotherapy facilities, including the first private proton therapy center in the Russian Federation. The institute provides comprehensive cancer care using state-of-the-art technologies such as Gamma Knife, CyberKnife, and linear accelerators, alongside a robust diagnostic infrastructure including PET-CT and molecular genetics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sergey Berezin Medical Institute.